Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include Verzenio for cancer; Mounjaro, Zepbound, Jardiance, Trulicity, Humalog, and Humulin for cardiometabolic; and Taltz and Olumiant for immunology.
The current price of Eli Lilly And Co in the market is Rp 15.248.177,79, with a 24-hour trading volume of Rp 59,27T. The asset's market cap is Rp 13,62P, after moving -3.67% in the last day.
Tokenized Eli Lilly And Co is trading at Rp 15.234.729,34, with a tokenized market cap of Rp 81,68B and a 24-hour trading volume of Rp 35B. The tokenized asset has moved -3.49% in the past 24 hours.